JOHN BUCHANAN: Open Payments
NPI 1265001184 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 13 payments from 8 companies in 2025. Trend: 2023 $3,369 · 2024 $1,638 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $119 |
| Boston Scientific Corporation | 2 | $59 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| PFIZER INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: REPATHA, VERQUVO, General - Erectile Dysfunction, LifeVest, FARXIGA, Rybelsus, VYNDAQEL, Kerendia.
Industry payments across GA — which companies pay providers there.
